Ascend Medical Technology (Uk) Ltd was officially closed on 2023-10-17.
Ascend Medical Technology (UK) was a private limited company that was located at Unit 2 The Pound, Coate, Devizes, SN10 3LG, Wiltshire, ENGLAND. Its net worth was estimated to be around 0 pounds, while the fixed assets belonging to the company amounted to 0 pounds. The company (formed on 2017-11-27) was run by 1 director.
Director Nigel H. who was appointed on 27 November 2017.
The company was officially categorised as "disinfecting and exterminating services" (81291), "research and experimental development on biotechnology" (72110).
As stated in the CH information, there was a name change on 2022-02-09 and their previous name was Cell4pharma (UK). There is a second name alteration mentioned: previous name was Ascend Life Science (als) performed on 2020-05-29.
The most recent confirmation statement was sent on 2022-07-01 and last time the accounts were sent was on 30 November 2021.
| Office Address | Unit 2 The Pound |
| Office Address2 | Coate |
| Town | Devizes |
| Post code | SN10 3LG |
| Country of origin | United Kingdom |
| Registration Number | 11083185 |
| Date of Incorporation | Mon, 27th Nov 2017 |
| Date of Dissolution | Tue, 17th Oct 2023 |
| Industry | Disinfecting and exterminating services |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 30th November |
| Company age | 6 years old |
| Account next due date | Thu, 31st Aug 2023 |
| Account last made up date | Tue, 30th Nov 2021 |
| Next confirmation statement due date | Sat, 15th Jul 2023 |
| Last confirmation statement dated | Fri, 1st Jul 2022 |
Position: Director
Appointed: 27 November 2017
Cell4pharma Bv
Pivot Park Life Sciences Community 9, Kloosterstraat 9, Kloosterstraat, 5349AB OSS, Netherlands
| Legal authority | Netherlandands |
| Legal form | Bv |
| Country registered | Netherlands |
| Place registered | Netherlands |
| Registration number | 77843 592 |
| Notified on | 23 June 2020 |
| Nature of control: |
50,01-75% shares 50,01-75% voting rights right to appoint and remove directors |
Nigel H.
| Notified on | 27 November 2017 |
| Nature of control: |
75,01-100% shares |
| Cell4pharma (UK) | February 9, 2022 |
| Ascend Life Science (als) | May 29, 2020 |
| Ascend Medical-technologies (amt) | August 23, 2018 |
| Profit & Loss | |
|---|---|
| Accounts Information Date | 2018-11-30 |
| Balance Sheet | |
| Net Assets Liabilities | 100 |
| Other | |
| Net Current Assets Liabilities | 100 |
| Number Shares Issued Fully Paid | 100 |
| Par Value Share | 1 |
| Total Assets Less Current Liabilities | 100 |
| Type | Category | Free download | |
|---|---|---|---|
| GAZ1(A) |
First Gazette notice for voluntary strike-off filed on: 1st, August 2023 |
gazette | Free Download (1 page) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy